Value of postoperative radiochemotherapy after completely resected gastric cancer not definitive despite negative overall results of the ARTIST trial;Stellenwert der postoperativen Radiochemotherapie beim kurativ resezierten Magenkarzinom trotz negativem Gesamtergebnis der ARTIST-Studie nicht abschlieend zu bewerten

Strahlentherapie und Onkologie

Volumn 188, Issue 7, 2012, Pages 636-637

  Lordick, F ^a  

^a KLINIKUM BRAUNSCHWEIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER PATIENT; CANCER SURGERY; CHEMORADIOTHERAPY; GASTRECTOMY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; NOTE; POSTOPERATIVE CARE; STOMACH CANCER; TREATMENT OUTCOME;

EID: 84862665111     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-012-0133-0     Document Type: Note

References (4)

1. Dikken JL, Jansen EP, Cats A et al (2010) Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer. J Clin Oncol 28:2430-2436
2. Macdonald JS, Smalley SR, Benedetti J et al (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345:725-730
3. Möhler M et al (2011) S3-Leitlinien-Kommission Magenkarzinom- Diagnostik und Therapie der Adenokarzinome des Magens und ösophago- gastralen Übergangs. Z Gastroenterol 49:461-531
4. Songun I, Putter H, Kranenbarg EM et al (2010) Surgical treatment of gastric cancer: 15-year follow-up results of the randomized nationwide Dutch D1D2 trial. Lancet Oncol 11:439-449